Eight sarcomatoid carcinoma were analyzed for the presence of EGFR kinase domain mutations, KRAS mutations, HER2 kinase domain mutations, BRAF mutations, ALK fusions, RET fusions and AKT1 mutations. The gene discussed is KRAS; the disease is sarcomatoid carcinoma.